Does Wearing Compression Garments Affect Sleep in Soccer Players

August 30, 2026 updated by: Wael Daab, Universite de Picardie Jules Verne

Does Wearing Compression Garments Affect Sleep in Soccer Players? A Randomized-controlled Cross-over Study From a Professional Soccer Club Academy

This study investigated the effects of nocturnal compression garments on sleep quantity and quality in young elite male soccer players. Eighteen players participated in a randomized controlled crossover protocol conducted over four consecutive weeks. During the first week, participants completed a control condition without wearing compression garments. During the following three weeks, they completed three experimental conditions in randomized order: full compression leggings, compression calf sleeves, and non-compressive placebo garments. Each condition was performed for seven consecutive nights. Objective sleep parameters were assessed using actigraphy, while subjective sleep quality was evaluated using validated self-report measures. Training load, perceptual factors, pre-sleep nutrition, and nocturnal thermal conditions were monitored and controlled to limit potential confounding factors. The primary objective was to determine whether nocturnal compression garment use affects sleep quantity and quality in young elite soccer players.

Study Overview

Detailed Description

This randomized controlled crossover study was conducted in young elite male soccer players from a professional soccer club academy to investigate the effects of nocturnal compression garments on sleep quantity and quality.

The study was conducted over four consecutive weeks. During the first week, all participants completed a baseline control condition without wearing any garment during the night. This baseline condition was always performed first and was not randomized. During the following three weeks, participants completed three garment conditions in a randomized order: full-length compression leggings, compression calf sleeves, and non-compressive placebo garments. Each condition was maintained for seven consecutive nights.

Participants were instructed to put on the assigned garment approximately two hours before bedtime, wear it throughout the night, and remove it after waking. The placebo garment was designed to provide a similar wearing experience without applying meaningful compression.

Sleep was assessed objectively using wrist actigraphy and subjectively using self-reported sleep measures. Objective sleep variables included total sleep time, time in bed, sleep latency, sleep efficiency, and the number of nocturnal awakenings.

To limit potential confounding factors, external and internal training loads, perceived stress, fatigue and muscle soreness, pre-sleep nutritional intake, and nocturnal thermal conditions were monitored throughout the experimental period. The study was conducted under standardized living and training conditions within the professional soccer academy environment.

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Avion, France, 62210
        • Centre technique et sportif de la Gaillette Gervais Martel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Residence at the professional soccer academy throughout the study period.
  • Abstinence from tobacco and alcohol throughout the study period.
  • No caffeine intake within 12 hours before bedtime.
  • Absence of sleep deficit at inclusion.
  • Absence of illness at inclusion.

Exclusion Criteria:

  • Sustaining an injury during the study period.
  • Exposure to a training load substantially different from that of the rest of the group.
  • Development or presence of a sleep deficit during the study period.
  • Failure to consume the standardized evening meal provided at the academy cafeteria.
  • Consumption of caffeine, tobacco, or alcohol during the study period.
  • Removal of the assigned garment or actigraphy device during the night.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sequence 1: Leggings - Calf Sleeves - Placebo
Participants wore fullcompression leggings from approximately two hours before bedtime until waking for seven consecutive nights.
Participants wore compression calf sleeves from approximately two hours before bedtime until waking for seven consecutive nights.
Participants wore visually similar non-compressive placebo garments from approximately two hours before bedtime until waking for seven consecutive nights.
Experimental: Sequence 2: Calf Sleeves - Placebo - Leggings
Participants wore fullcompression leggings from approximately two hours before bedtime until waking for seven consecutive nights.
Participants wore compression calf sleeves from approximately two hours before bedtime until waking for seven consecutive nights.
Participants wore visually similar non-compressive placebo garments from approximately two hours before bedtime until waking for seven consecutive nights.
Experimental: Sequence 3: Placebo - Leggings - Calf Sleeves
Participants wore fullcompression leggings from approximately two hours before bedtime until waking for seven consecutive nights.
Participants wore compression calf sleeves from approximately two hours before bedtime until waking for seven consecutive nights.
Participants wore visually similar non-compressive placebo garments from approximately two hours before bedtime until waking for seven consecutive nights.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Sleep Time
Time Frame: Assessed nightly during each 7-night condition
Assessed nightly during each 7-night condition
Time in Bed
Time Frame: Assessed nightly during each 7-night condition
Assessed nightly during each 7-night condition
Sleep Latency
Time Frame: Assessed nightly during each 7-night condition
Assessed nightly during each 7-night condition
Mean Sleep Efficiency Assessed by Wrist Actigraphy
Time Frame: Measured nightly and averaged across the 7 consecutive nights of each condition
Sleep efficiency was assessed by wrist actigraphy and calculated as the percentage of time in bed spent asleep. Nightly sleep efficiency values were averaged across the seven consecutive nights of each experimental condition. Higher values indicate greater sleep efficiency.
Measured nightly and averaged across the 7 consecutive nights of each condition
Number of Nocturnal Awakenings
Time Frame: Assessed nightly during each 7-night condition
Assessed nightly during each 7-night condition
Subjective Sleep Quality Assessed Using the Sleep Item of the Hooper Questionnaire
Time Frame: Assessed nightly during each 7-night condition
Subjective sleep quality was assessed using the sleep-quality item of the Hooper Questionnaire (Hooper et al., 1995). Participants rated the quality of the previous night's sleep on a 7-point Likert-type scale ranging from 1 (very, very good) to 7 (very, very bad), with higher scores indicating poorer perceived sleep quality.
Assessed nightly during each 7-night condition

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 2, 2025

Primary Completion (Actual)

December 14, 2025

Study Completion (Actual)

December 14, 2025

Study Registration Dates

First Submitted

August 25, 2026

First Submitted That Met QC Criteria

August 30, 2026

First Posted (Actual)

September 3, 2026

Study Record Updates

Last Update Posted (Actual)

September 3, 2026

Last Update Submitted That Met QC Criteria

August 30, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • UPJV-COMP-SLEEP-01
  • 2024-10-1/2024-46 (Other Identifier: Comité d'éthique pour les recherches non interventionnelles (CERNI), Université de Picardie Jules Verne)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe